IDH1 and intrahepatic cholangiocarcinoma: As shown in Figure 6C, JQ1 and Vorinostat significantly inhibited Cluster2A (IDH1 mutant) ICC cells, but not Cluster1A (KRAS/TP53 mutant) ICC cells.